In industrial settings, exposure to calcium pyrophosphate is managed through standard occupational safety measures. Workers are advised to use personal protective equipment (PPE) to minimize inhalation or dermal exposure. In the case of CPPD, management focuses on alleviating symptoms through anti-inflammatory medications and other treatments aimed at reducing crystal-induced inflammation.
